Literature DB >> 34801696

Impact of immune cells on the hallmarks of cancer: A literature review.

Alexandra C Costa1, Joana M O Santos2, Rui M Gil da Costa3, Rui Medeiros4.   

Abstract

Tumor-infiltrating immune cells (TIICs) are critical players in the tumor microenvironment, modulating cancer cell functions. TIICs are highly heterogenic and plastic and may either suppress cancers or provide support for tumor growth. A wide range of studies have shed light on how tumor-associated macrophages, dendritic cells, neutrophils, mast cells, natural killer cells and lymphocytes contribute for the establishment of several hallmarks of cancer and became the basis for successful immunotherapies. Many of those TIICs play pivotal roles in several hallmarks of cancer. This review contributes to elucidate the multifaceted roles of immune cells in cancer development, highlighting molecular components that constitute promising therapeutic targets. Additional studies are needed to clarify the relation between TIICs and hallmarks such as enabling replicative immortality, evading growth suppressors, sustaining proliferative signaling, resisting cell death and genome instability and mutation, to further explore their therapeutic potential and improve the outcomes of cancer patients.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Immune system; Immunotherapy; Prognosis; Tumor-infiltrating immune cells (TIICs)

Mesh:

Year:  2021        PMID: 34801696     DOI: 10.1016/j.critrevonc.2021.103541

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  7 in total

Review 1.  Nerves in gastrointestinal cancer: from mechanism to modulations.

Authors:  Nathalie Vaes; Musa Idris; Werend Boesmans; Maria M Alves; Veerle Melotte
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

2.  Characterizing the Inflammatory Microenvironment in K14-HPV16 Transgenic Mice: Mast Cell Infiltration and MicroRNA Expression.

Authors:  Alexandra C Costa; Joana M O Santos; Beatriz Medeiros-Fonseca; Paula A Oliveira; Margarida M S M Bastos; Haissa O Brito; Rui M Gil da Costa; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 3.  Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.

Authors:  Haoran Li; Kamal K Sahu; Benjamin L Maughan
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

4.  It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer.

Authors:  Ingrid Garajová; Andrea Cavazzoni; Michela Verze; Roberta Minari; Giuseppe Pedrazzi; Rita Balsano; Fabio Gelsomino; Raffaele Dalla Valle; Graziana Digiacomo; Elisa Giovannetti; Francesco Leonardi
Journal:  Life (Basel)       Date:  2022-06-26

5.  Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.

Authors:  Longfei Yang; Yuwei Zhang; Yang Wang; Peng Jiang; Fengping Liu; Ninghan Feng
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

6.  Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma.

Authors:  Ye Yang; Min Wang
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

7.  Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes.

Authors:  Fabrizio Mattei; Sara Andreone; Francesca Spadaro; Francesco Noto; Antonella Tinari; Mario Falchi; Silvia Piconese; Claudia Afferni; Giovanna Schiavoni
Journal:  iScience       Date:  2022-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.